I. Introduction
Hemophilia is a genetic disorder linked to x chromosome. Males suffering from this disorder mostly lack either clotting factor vii or ix. In rare cases there may be deficiency of other factors. As a result they loose substantial amount of blood due to injuries or spontaneous bleeding. They require to be treated with purified factors or fresh frozen plasma. With increase in age and activities there are chances of getting microbial infections due to multiple transfusions.
II. Materials and methods
At Hemophilia Society, Rajkot a group of 156 hemophilic patients were registered initially in the study, at the end of the study in 2008 we have registered 232 hemophilic patients. Transfusion and clinical records of all patients were maintained throughout the study.
Serological study
Frozen samples were tested after the study period for various viral markers in the same laboratory by one person using the same batches of reagents and kits. Tests were carried out by commercially available, third generation, enzyme linked immunosorbent assay (ELISA) for the following TTD markers: (i) HBsAg (Microscreen HbsAg ELISA Test Kit by Span Diagnostics) (ii) antibodies to HCV (SP-NANBASE C-96 3.0 test kit by General Biological Corp.); (iv) anti HIV I/II (Enzaids HIV 1+2 ELISA test kit by Span Diagnostics). Tests could not be repeated due to lack of serum samples and in some cases because of high reagent cost.
III. Results
Hemophilia a hereditary disorder of Coagulation results in deficiency of Factor VIII (Hemophilia A) or Factor IX (Hemophilia B) or rarely due to deficiency of other clotting factors. Hemophilia is a chronic physical condition affecting the child from birth. Age group wise distribution was studied. Figure indicates majority of the hemophilia patients under present study belonged to age group between 16 and 30 followed by 6-15 years, above 31 years of age and least number of patients were in 0-5 year age group. This data suggests good prenatal counseling and efficient management of the disease in patients. Hemophilia can be mild, moderate, or severe, depending on how much clotting factor is in the blood. We carried out factor estimation in order to establish severity of the disease. Figure shows Factor level in most hemophilia patients was found to be either below 1(40.94%) or between 1 and 5 (36.64%). There were 52 (22.42%) patients with factor level of more than 5. Majority of the patients under our study have severe hemophilia.
Distribution of Hemophilia patients according to Factor Level
Prevalence of Viral infections among Hemophilic Patients Table 3 Figure shows that out of 232 patients, only 1 patient was found to be HBsAg positive and 1 was HCV positive. All patients were HIV negative. Because of the advanced procedures of inactivation of viruses such infections are less likely to occur.
IV. Discussion
Blood transfusion currently faces interesting challenges. While advances have been dramatic, both in terms of technology and organizational up gradation in developed countries, blood transfusion in developing countries still tend to stagnate with acute shortages, lack of component therapy and safety problems.
HBsAg HCV seropositivity in hemophilic patients found to be varying from 100% to 0.43% in various studies. As explained earlier policy of giving single donor cryoprecipitate to hemophiliacs is the reason of low seropositivity in our study.
Because of the enormous risk involved in transmission of HIV through blood, safety of blood and blood product is of paramount importance. Currently, the risk of transmission of HIV through transfusion is minimal, because effective preventive strategies, including new laboratory tests, have been implemented. The virus that causes AIDS (HIV) can be carried in clotting factors as well as plasma. However, there has been no documented case of these viruses being transmitted during replacement therapy in our present study. Transmission of viruses has been prevented by careful screening of blood donors, testing of donated blood products, treating donated blood products with a detergent and heat to destroy viruses.
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